未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Phase 1b study of first-line fuzuloparib combined with modified FOLFIRINOX followed by fuzuloparib maintenance monotherapy in pancreatic adenocarcinoma (vol 22, 365, 2024) 胰腺腺癌中,将fuzuloparib联合改良FOLFIRINOX作为一线治疗,随后进行fuzuloparib维持单药治疗的Phase 1b研究(卷22,365,2024) Wei, Miaoyan; Liu, Rujiao; Xu, Yunyun; Chen, Xiaobing; Liu, Chao; Bai, Xueli; Zhang, Xiaochen; Gao, Shuiping; Li, Jialin; Sheng, Zhen; Lian, Jianpo; Wang, Wenliang; Zhang, Jian; Shi, Si; Xu, Jin; Yu, Xianjun 分享 收藏
The pancreatitis-cancer transformation-related factor, human rhomboid family-1, promotes pancreatic cancer progression through the SRC/YAP signaling pathway 胰腺炎-癌转化相关因子,人Rhomboid家族-1,通过SRC/YAP信号通路促进胰腺癌进展。 Ma, Zhilong; Hua, Jie; Wei, Miaoyan; Han, Lin; Dong, Mingwei; Xie, Wangcheng; Luo, Tingyi; Meng, Qingcai; Wang, Wei; Song, Zhenshun; Shi, Si; Yu, Xianjun 分享 收藏
分享 收藏
The novel GSDMD inhibitor GI-Y2 exerts antipyroptotic effects to reduce atherosclerosis 新型GSDMD抑制剂GI-Y2发挥抗焦亡作用以减轻动脉粥样硬化 Fan, Xiaoxi; Cheng, Zhenfeng; Shao, Ruiyin; Ye, Keke; Chen, Xudong; Cai, Xueli; Dai, Shanshan; Tang, Zhixuan; Shi, Si; Zheng, Wenyuan; Huang, Weijian; Han, Jibo; Ye, Bozhi 分享 收藏
Retrospective analysis of disease characteristics and treatment patterns among patients with esophageal cancer across 14 surgically represented centers Lu, Zhihao; Geng, Mingfei; Han, Yongtao; Cao, Jianzhong; Wang, Jun; Liu, Tianshu; Yuan, Xianglin; Meng, Xue; Zhang, Yanqiao; Zhao, Rong; Wan, Lixin; Li, Enxiao; Wang, Wenran; Li, Zhijie; Shi, Danfeng; Qian, Jing; Shi, Si; Dong, Fengshi; Shen, Lin 分享 收藏
分享 收藏
分享 收藏